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In general, calcification of biomaterials occurs through an interaction of host and implanted 
material factors, but up to now the real origin of pathologic calcification is unknown. In this 
study we aimed to investigate incidence of calcification of (crosslinked) dermal sheep 
collagens (DSCs) with respect to their specific properties, during subcutaneous implantation 
in rats. Three types of DSCs were commercially obtained: non-crosslinked DSC (NDSC), and 
DSC crosslinked with glutaraldehyde (GDSC) and hexamethylenediisocyanate (HDSC). 
NDSC, HDSC and GDSC were (enzymatically) tissue culture pretreated to eliminate their 
cytotoxic products. Beside this, crosslinking methods were modified to optimize mechanical 
properties and to decrease cytotoxicity, which resulted in HDSC* and GDSC*. Furthermore, 
DSC was crosslinked by activation of the carboxylic groups, i.e. by means of acyl azide and 
carbodiimide, resulting in AaDSC and CDSC, respectively. After implantation of HDSCs and 
GDSCs a relation between cytotoxicity and calcification of crosslinked DSC could be made. 
No relation was found between cellular infiltration of DSCs and calcification. However, from 
the use of different types and modification of crosslinking methods it might be concluded 
that calcification is mainly related to stable crosslinks, i.e. to the chemical properties of the 
obtained material. 
1. Introduction 
Crosslinked collagen or tissue-derived biomaterials 
rich in collagen are widely used for clinical applica- 
tions. However, calcification, resulting in degeneration 
of these materials, is a major disadvantage in applica- 
tions such as bioprosthetic heart valves [l-7]. 
Up to now the origin of collagen calcification is not 
well understood. Several factors can be involved in 
this process, such as the type of biomaterial (e.g. degree 
of crosslinking, positive and negative charged amino 
acids), host cellular materials and application sites. 
To inhibit calcification, treatment of glutaraldehyde 
(GA) crosslinked collagens with, for example, pro-. 
tamine sulphate [S, 91, by controlled release of diphos- 
phonates [lo-131, or L-glutamine acid treatment [14] 
in order to block residual aldehyde groups, have been 
studied. Furthermore, pretreatment with epoxy com- 
pounds [ 151, which can both link amino- and car- 
boxylgroups, was performed before GA crosslinking. 
With all models at least some reduction in calcifica- 
tion was observed. 
Thus far only three groups studied the use of differ- 
ent crosslinking, i.e. by use of acyl azide, or by use of 
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cyanamide [16-183, to prevent calcification of the 
material. The latter is less attractive because it has 
limited crosslinking ability and seemed to be effective 
only in combination with iron (III) citrate [16]. 
Our group has studied collagen from a different 
viewpoint. Both in vitro [19-221 and in uivo [23-261 
studies were performed with dermal sheep collagens 
(DSC). Optimization or development of new cross- 
linking methods was first aimed at preventing 
cytotoxic effects and decreasing degradation rates. 
In the present study we focused on calcification. The 
incidence of calcification of DSCs upon subcutaneous 
implantation in rats was evaluated in relation to 
cytotoxicity, to cellular interactions and to chemical 
modifications induced by different crosslinking 
methods. 
2. Materials and methods 
2.1. Materials 
Dermal Sheep Collagen (DSC), processed from 
sheep skin [27, 281, was obtained from the Zuid 
Nederlandse Zeemlederfabriek, Oosterhout, The 
0957-4530 0 1995 Chapman & Hall 
Netherlands. Three groups of DSCs were used: 
(A) commercially available DSCs; 
(B) commercially available DSCs, which had been 
incubated in tissue culture and thereafter showed 
a decreased cytotoxicity; and 
(C) modified DSCs, i.e. optimized versions of the com- 
mercially crosslinked DSCs, and new DSCs cross- 
linked after first activating carboxylic acid groups 
within the collagen. 
Group (A) Three types of DSC were commercially 
available. If non-crosslinked, the material is further 
called NDSC (batch 409-018). Furthermore two types 
of DSC crosslinked with bifunctional agents were ob- 
tained: HDSC (batch 392-OOl), which was crosslinked 
with hexamethylenediisocyanate (HMDIC) and 
GDSC (batch 397-OlO), which was crosslinked with 
glutaraldehyde (GA). In short, HDSC was crosslinked 
for 15 h at pH 7.5, with a HMDIC-solution of 1.25% 
(Desmodur@) containing 0.3% of surfactant (Emulvin 
W@), both obtained from Bayer, Wuppertal, Ger- 
many. GDSC was crosslinked for 17.5 h with a 0.5% 
GA-solution (Regulan CT 50@ obtained from BASF, 
Basel, Switzerland), by slowly raising the pH from 5 to 
7. Discs with a diameter of 8 mm were punched from 
HDSC, GDSC and NDSC. The individual weights 
were approximately 15 mg and all discs were sterilized 
by gamma irradiation, 2.5 Mrad (Gammaster, Ede, 
The Netherlands). 
Group (B) Sterilized commercially available DSC- 
discs were incubated in tissue culture, the so-called 
methylcelluose (MC)-cell culture (in detail described 
by van Luyn et al. [19,21], see below: in vitro cytoxic- 
ity testing). 
HDSC-discs were exposed four times (4 x 6 days) to 
MC-cell culture [20], while both GDSC and NDSC 
were pretreated during two exposure periods (Fig. 1). 
Thereafter culture-gel remnants were removed by 
wiping with sterile gauze. These tissue culture (tc)- 
pretreated discs, are further referred to as NDSCtc, 
GDSCtc or HDSCtc (Fig. 2). 
Group (C) To modify DSCs, NDSC was first washed 
four times with distilled water, twice with acetone, and 
again twice with distilled water. The material was 
thereafter frozen and lyophilized, followed by four 
different crosslinking methods. 
Modifications of commercial crosslinking methods 
with bifunctional agents HMDIC and GA resulted in 
two optimized versions. 
Preparation of Tissue Culture (TC) pretreated DSC’s 
disc-2x up to diw6x 
6 days culture 6 days culture 
Figure I Scheme of the indirect testing of dermal sheep collagen 
(DSC) with the methylcellulose cell culture and the repeated expo- 
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Figure 2 Cell proliferation inhibition indices (CPIIs) of HDSC, 
GDSC and NDSC after six or seven day culture periods in methyl- 
cellulose cell culture. The arrows indicate the samples used for in 
uivo studies, i.e. discs of HDSCtc after four culture periods and for 
GDSCtc and NDSCtc after two culture-periods. 
For HMDIC-crosslinking [29-311, 1 g samples 
were crosslinked in 100 ml phosphate buffer (0.07 M 
NaH2P04, pH 9.5) containing 1.5% (w/w) HMDIC 
(z.S., Merck-Schuchardt, Hohenbrunn, FRG) and 
1.0% (w/w) Tween 80 (z.S., Merck-Schuchardt, 
Hohenbrunn, FRG) as a surfactant for 5 h at room 
temperature. After crosslinking the samples were rin- 
sed for 30 min by running tap, washed twice for 
30 min with 4 M NaCl and washed four times for 
30 min with distilled water to remove unreacted 
HMDIC or surfactant before lyophilization. The re- 
sulting DSC is further referred to as HDSC*. 
GA-crosslinking [29, 311 was performed by immers- 
ing 1 g samples in 100 ml phosphate buffer (0.054 M 
Na2HP04, 0.013 M NaH2P04, pH 7.4) containing 
0.5% (w/w) purified GA for 1 h at room temperature. 
Directly after crosslinking, samples were immersed in 
a freshly prepared 1.2 mg/ml solution of NaBH4 (Jan- 
ssen Chimica, Beerse, Belgium) in phosphate buffer 
(pH 7.4) for 1 h to reduce any unstable compounds. 
Thereafter, the samples were rinsed for 30 min by 
running tap, washed twice for 30 min with 4 M NaCl 
and washed four times for 30 min with distilled 
water. The resulting DSC is further referred to as 
GDSC”. 
With the two other methods, acyl azide and car- 
bodiimide crosslinking, first carboxylic acid groups 
were activated and thereafter linked with amine- 
groups within the collagen [29, 31, 33-351. 
With acyl azide (Aa)-crosslinking [29, 351, the car- 
boxylic acid groups of DSC were first ethylated by 
treating 1 g samples for 6 days during constant mixing 
in 35 ml ethanol (p.a., E. Merck, Darmstadt, FRG) 
containing 0.2 M HCl. The samples were then washed 
with a 0.5 M NaCl solution and the ethyl ester groups 
were converted to hydrazides by immersing the sam- 
ples in 100 ml of a 5.0% (w/w) solution of hydrazine 
(monohydrate, 99%, Janssen Chimica, Geel, Belgium) 
in 0.5 M NaCl for 24 h at room temperature. After 
hydrazide formation, samples were washed with an ice 
cold 0.5 M NaCl solution. Acyl azide formation was 
performed in 100 ml of a 0.5 M NaCl solution contain- 
ing 0.5 M NaNO, (E. Merck, Darmstadt, FRG) and 
0.3 M HCl at 0 “C for 10 min. Washing with 0.02 M 
Na2HP0, buffer (pH 8.9) containing 0.5 M NaCl was 
the next step, followed finally by the crosslinking by 
reaction of acyl azide groups with amine groups in 
200 ml buffer (pH 8.9) containing 0.5 M NaCl at room 
temperature for 48 h. Thereafter, samples were washed 
twice with 4 M NaCl and four times with water before 
lyophilization. Samples are further called AaDSC. 
Carbodiimide-crosslinking was performed with 
EDC ((l-ethyl-3-(3 dimethyl aminopropyl) carbodiim- 
ide hydrochloride)) in combination with NHS ((n-hy- 
droxysuccinimide)) to suppress side reactions [29, 33, 
351. Samples of 1 g were immersed in 50 ml aqueous 
solution containing 1.15 g (6.0 mmol) EDC (Merck- 
Schuchardt, Hohenbrun, FRG) and 0.28 g (2.4 mmol) 
NHS (also from Merck-Schuchardt) at room temper- 
ature for 2 h. The pH of the solution was set at 5.5 by 
the addition of HCl and maintained at this value by 
addition of 0.1~ NaOH using a pH stat apparatus 
(702 SM Titrino, Metrohm, Herisau, Switzerland). 
After crosslinking samples were washed for 2 h in 
a 0.1 M Na2HP04 solution to hydrolyze any remain- 
ing NHS-activated carboxylic groups and sub- 
sequently washed four times with distilled water be- 
fore lyophilization. This material is further referred to 
as ENDSC. 
The degree of crosslinking of HDSC”, GDSC”, 
AaDSC and ENDSC was related to the increase in 
shrinkage temperature [35, 361. Shrinkage temper- 
atures (T,) of non-sterilized (crosslinked) DSC samples 
were determined using a shrinkage temperature tester. 
Test specimens were cut (5 mm x 5 mm), mounted and 
immersed in water for at least 30 min. A heating rate 
of 2.5 “C/min was applied and the onset of shrinkage 
was recorded as the T,. 
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Discs with a diameter of 8 mm were punched. The 
weight was approximately 15 mg. All discs of this 
group were sterilized by ethylene-oxide. 
2.2. In vitro cytotoxicity testing 
DSCs of group B had been exposed several times to 
tissue culture, i.e. methylcellulose (MC)-cell culture 
(Fig. 2). DSCs of groups A and C were exposed to 
tissue culture only once to obtain the degree of 
cytotoxicity. 
Cells to be used in MC-cell culture, i.e. human skin 
fibroblasts (HF, established cell-line PK 84), were 
routinely cultured in RPM1 1640 medium (Gibco Bio- 
cult Co, Paisley, UK), supplemented with 10% fetal 
calf serum (FCS), 2mM/ml glutamine (Glut) (Merck, 
Darmstadt, FRG), penicillin and streptomycin, both 
100 U/ml (Gibco). After washing twice with phos- 
phate-buffered saline (PBS) (NPBI, Emmer-Compas- 
cuum, The Netherlands), HF were harvested from 
routine culture using 0.25% trypsin in Ca+ ‘/Mg+ +- 
free Hanks’ Salt Solution (Gibco). 
A stock solution of MC, Methocel high viscosity 
(3000&4000 cps) from Fluka, Bio Chemica, Buchs, 
Switzerland, was prepared according to Iscove et al. 
[37], with Iscove‘s modification of Dulbecco’s me- 
dium (IMDM) (ICN Biomedicals Inc., Costa Mesa, 
CA, USA) in a final concentration of 2.25%. 
MC/HF mixtures were made by gently and thor- 
oughly mixing HF/IMDM (30%) with MC (50%) and 
FCS (20%). Pen, Strep and Glut had been added to 
IMDM in order to obtain the same final concentra- 
tion in the culture gel as described for RPM1 1640 
medium. A final volume of 4.0 ml of culture-gel con- 
taining 5 x lo4 HF was placed into each well of 6-well 
tissue culture plates (Greiner, Alphen a/d Rijn, The 
Netherlands). Cultures were either used as control 
cultures or, when discs were placed on the culture gel, 
as test cultures. All cultures were incubated at 37 “C in 
air containing 5% COZ. 
2.3. Cell counts 
After culturing, discs and gel were removed. The cell 
layers remaining on the bottom of the wells were 
extensively washed with PBS in order to completely 
remove the gel; The cells were trypsinized, resusp- 
ended and counted in a Biirker counting chamber. 
The cell proliferation inhibition index (CPII), ex- 
pressed as a percentage of cell proliferation in control 
culture, was calculated as follows: 
cm(%) = 100% - 
mean cell number of culture with discs 
mean cell number of control culture 
x 100% 1 
Cell numbers were calculated as the mean of counts 
+ s.d. (n = 3). 
2.4. Implantations 
Albino Oxford (AO) rats, 3 months of age, were ether- 
anaesthetized and subcutaneous pockets were made 
to the right and left of two midline incisions. DSC 
discs were implanted in the pockets at a distance of 
about 1 cm from the incisions on the back [23, 241. 
Implants with surrounding tissue were harvested at 
5 or 10 days and in case of groups A and C also at 3,6, 
10, 15 and, if not degenerated, at 20 and 30 weeks 
(n = 3). 
2.5. Microscopy 
Implants were fixed in 2% (v/v) GA in 0.1 mol PBS. 
Specimens were cut into small blocks (2 mm”) after at 
least 24 h of fixation at 4 “C. 
Blocks were postfixed in 1% OsO,, 1.5% 
K,Fe(CN), in PBS [38], dehydrated in graded alco- 
hols and embedded in Epon 812. Semithin sections 
(1 pm) were made of several levels of each block and 
stained with toluidine blue. Light microscopical evalu- 
ations were performed double blind concerning cellu- 
lar events and calcification. 
Ultrathin sections of the same levels were cut and 
stained with uranyl acetate and lead citrate and exam- 
ined with a Philips EM 201 transmission electron 
microscope, operated at 40 kV. 
3. Results 
3.1. Initial properties 
NDSC, the non-crosslinked version of processed der- 
ma1 sheep collagen, had a shrinkage temperature (T,) 
of 56.0 $- 0.3 “C. The modified DSCs of group C had 
increased T, values, indicating that crosslinking had 
occurred [29-351. The HMDIC-crosslinked HDSC* 
had the lowest T, of 73.8 + 0.3”C, while the GA- 
crosslinked GDSC” had a T, of 77.7 _+ 0.3 “C. The 
acyl-azide-crosslinked AaDSC and the EDCNHS- 
crosslinked ENDSC had a T, of, respectively, 
82.4 + 0.4 and 86.6 f 0.4”C. 
NDSC had a fibrous structure, whitish colour and 
supple hand. All other DSCs had the same fibrous 
structure. HDSC, HDSC*, AaDSC and ENDSC all 
had the same whitish colour. In contrast both GDSC 
and GDSC* had a more yellowish colour. ENDSC 
was the only DSC with some decrease in suppleness as 
well as wettability. 
3.2. Cytotoxicity (Table I) 
The commercially available DSCs of group A were 
one-time-exposed to HF in MC cell culture. NDSC 
induced an inhibition of cell proliferation of 20%, as 
measured after 6 days of exposure to human fibrob- 
lasts (HF). The morphology of the HF was normal as 
compared to the control culture. 
Cultures with discs of HDSC showed an inhibition 
of cell proliferation of 50% with moderate lipid degen- 
eration of HF at the edge of the cell-free zone. Com- 
mercially available GDSC induced a very high level of 
cytotoxicity with 85% cell growth inhibition, large 
cell-free zones and lipid-degenerative effects. 
Further exposure to tissue culture (group B) was 
found to remove or considerably decrease in vitro 
cytotoxic effects (see also Fig. 2.) After being exposed 
TABLE I Cytotoxicity of DSCs, expressed as the cell proliferation 




NDSC 20.8 & 1.0 normal 
HDSC 51.5 + 5.3 moderate lipid degeneration 
GDSC 86.9 T 0.6 high lipid degeneration 
NDSCtc 6.4 + 1.6 normal 
HDSCtc 3.8 * 1.4 normal 
GDSCtc 1.9 + 1.9 low lipid degeneration 
HDSC* 13.4 & 10.4 normal 
GDSC* 15.8 * 10.2 low lipid degeneration 
ENDSC - 4.5 f 3.4 normal 
AaDSC - 2.2 * 4.9 normal 
for 2 x 6 days to HF in MC cell culture NDSCtc did 
no longer induce cell growth inhibition (and of course 
cell morphology was normal). HDSCtc needed to be 
exposed for 4 x 6 days in order to show no significant 
inhibition of cell proliferation and normal morpho- 
l%Y. 
A 10% cell growth inhibition was found for 
GDSCtc when exposed for 2 x 6 days; further expo- 
sure periods (performed up to seven times) did not 
further decrease this number [21]. 
Of the modified DSCs of group C, one-time-expo- 
sure to HF in MC cell culture resulted in a 13% 
inhibition of cell proliferation for HDSC*, without 
deviant morphology. The modified GDSC* induced 
a low cell growth inhibition of 16% with low lipid 
degeneration of cells at the edge of the very small 
cell-free zone. 
AaDSC and ENDSC neither induced inhibition of 
cell proliferation nor deviances in cell morphology as 
compared to the control culture. 
3.3. Cellular infiltration of DSCs (Table II) 
DSCs with cell growth inhibition percentages as de- 
tailed above were implanted. 
In general, neutrophils and macrophages were the 
very first cell types to arrive at the site of wounding 
and insertion of the foreign body. In the second in- 
stance, already observed from day 5 on but most 
prominently at day 10 and later time points, fibrob- 
lasts were present, while giant cells were being formed. 
The reaction of neutrophils and macrophages from 
day 10 on usually decreased. 
A cell type not normally present during the reaction 
to biomaterials, i.e. the basophil-like cell [23, 241, was 
locally found in all DSCs from day 5 on. These cells 
seemed specifically attracted by crystals sometimes 
present in all DSCs, but mostly so in GDSC. Further- 
more, some lymphocytes were observed in all DSCs 
from week 6 on. Details concerning the different DSCs 
are described below. 
Concerning materials of group A: with NDSC only 
few neutrophils were present at the edges, while mac- 
rophages were hardly observed. Also at later time 
points, e.g. from day 10 on, hardly any neutrophils or 
macrophages were found in NDSC. Similarly, fibrob- 
last ingrowth and giant cell formation was hardly or 
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TABLE II Cellular infiltration and morphology of implanted DSCs 
Days 5 and 10 
Infiltration Remarks 
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degen. week 15 
degen. week 15 
less rat-collagen 
new collagen matrix 
degen. > week 30 
new collagen matrix 
degen. > week 30 
not observed. NDSC had degenerated within 6 weeks. 
Moderate infiltration of neutrophils and macrophages 
was observed with HDSC. The neutrophils locally had 
deviant morphologies with disintegration of the 
cytoplasm. In the second instance a high infiltration of 
fibroblasts and giant cells was observed. The fibrob- 
lasts thereby produced new collagen, while giant cells 
degraded the material within 15 weeks by surrounding 
and enclosing parts of collagen bundles. 
In contrast, high cell numbers at first infiltrated 
GDSC; many cells, probably mostly neutrophils, had 
died leaving a lot of cell debris and lipid. Similarly to 
HDSC, fibroblast and giant cell infiltration occurred, 
followed by degradation at week 15. 
The tissue culture pretreated materials of group 
B were only observed at days 5 to 10. NDSCtc in- 
duced a tissue reaction which was similar to that of 
NDSC, i.e. hardly any cell infiltration occurred. 
Slightly more, although still not very many, neu- 
trophils and macrophages infiltrated HDSCtc. These 
cells had normal morphologies. Neutrophil infiltra- 
tion in GDSCtc was increased, while cells were strong- 
ly activated and had high concentrations of glycogen. 
Fibroblasts and giant cells infiltrated HDSCtc but not 
NDSCtc and GDSCtc. 
Concerning group C; few neutrophils were found to 
infiltrate HDSC”, AaDSC and ENDSC. Only in case 
of GDSC” an increase of neutrophils with disinteg- 
rated cytoplasm was observed. Macrophages infil- 
trated these materials in normal numbers, with the 
exception of AaDSC. The increased numbers of mac- 
rophages in the latter material contained many lipid 
droplets. From week 3 on a moderate/high infiltration 
of fibroblasts and giant cells was observed with 
HDSC*, AaDSC and ENDSC. The giant cells thereb,y 
degraded HDSC” within 15 weeks. In the case of 
AaDSC and ENDSC, at 20 and 30 weeks a matrix of 
collagen bundles, probably of rat origin, was obtained. 
GDSC* hardly induced fibroblast infiltration, while 
giant cells were also hardly present. As a consequence 
little new formation of rat collagen was observed and 
the material had degenerated within 15 weeks. 
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TABLE III Calcification of implanted DSCs 
Implantation period 
5d 10 d 3 wk 6 wk 10 wk 15 wk 20 wk 30 wk 
NDSC - - - - 
HDSC - ++ ++ - - 
GDSC - - - - - 
NDSCtc - - 
HDSCtc - 2 
GDSCtc + + 
HDSC* - - _ - - - 
GSC* - ++ +++ +++ +++ + 
ENDSC - - - ++ - - - - 
AaDSC - ~ + - - - - - 
3.4. Calcification during implantation 
(Table ill) 
By LM, the occurrence of calcification could be regis- 
tered by red spot-like or complete staining of the 
otherwise blue-stained collagen bundles. 
By TEM, the slightest incidence of calcification 
could be observed as deposits of (small) needle-like 
crystals or as large black areas which all contained 
calcium and phosphorus (as previously detected with 
X-ray micro-analyis [23]). 
Within group A, HDSC showed calcifications in the 
lo-day-to-3-week specimens. These were locally in the 
extracellular collagen bundles found in large deposits 
(Fig. 3). In contrast, with GDSC (Fig. 4) and NDSC 
no calcific deposits were found. 
The tissue-culture-pretreated DSCs of group B, 
only investigated at days 5 and 10 after implantation, 
showed calcifications with GDSCtc but not with 
NDSCtc and HDSCtc. The calcifications in GDSCtc 
were present as many small spots at both the edges of 
the collagen bundles as well as distributed over the 
collagen bundles (Fig. 5). The collagenous parts of 
GDSCtc as well as NDSCtc in general showed a more 
“degenerated” morphology (i.e. loss of fibrillar struc- 
ture, and sometimes a transition to a more gelatinous 
structure). In contrast, collagen bundles of HDSCtc, 
Figure 5 Very small deposits of calcium phosphate (arrows) in the 
collagen bundles of GDSCtc 10 days after implantation. Further- 
more the low cellular ingrowth, of mainly fibroblasts (F), is shown. 
Magnification 7142x. 
Figure 3 Electron-dense deposits of calcium phosphate (arrows) in 
the collagen bundles and high infiltration of cells present in HDSC 
14 days after implantation. Magnification 7142x. 
Figure 1 High presence of cell debris including lipid droplets (L) 
and myelin structures (M) in between the collagen bundles of GDSC 
10 days after implantation. Note: no calcification was observed in 
the bundles of GDSC. Magnification 4685x. 
although having been exposed to tissue culture twice 
as much, did not show a degenerated morphology. 
The modified materials of group C showed one. 
example with a high degree of calcification. GDSC” 
contained small deposits of calcifications, regularly 
distributed in all collagen bundles, in the lo-day speci- 
men (Fig. 6). Calcification increased and from week 
3 (Fig. 7) up to week 10 very large deposits were 
observed, which finally made it very difficult to recog- 
nize and retrieve the original matrix structure of 
GDSC* (Fig. 8a, b). Thereafter the calcific deposits 
seemed to disappear via some extracellular pathway. 
Thus, at week 15, only many small calcific deposits 
Figure 6 High percentage of calcium phosphate present in the col- 
lagen bundles of GDSC* and low ingrowth of cells after 10 days of 
implantation. Magnification 4685x. 
were observed, but the original matrix structure of 
GDSC* had completely disappeared (Table III). 
AaDSC and ENDSC only induced a little calcifica- 
tion in the collagen bundles of the 3- and 6-week 
implants, respectively (Figs 9 and 10). A collagen 
matrix, probably of rat origin, was still well retrieved 
after 20 and 30 weeks of implantation with AaDSC 
and ENDSC. 
With HDSC” at no time were deposits of calcifica- 
tion found. 
4. Discussion 
The aim of this study was to investigate the incidence 
of calcification of different (crosslinked) dermal sheep 
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Figure 7 Ongoing calcification of the collagen bundles of GDSC* Figure 9 Slight calcification within the collagen bundles of AaDSC 
3 weeks after implantation, with again ongoing very low cellular (arrows), which was only observed 3 weeks after implantation. 
ingrowth. Magnification 4685x. Magnification 4500x. 
Figure IO Small spots of calcium phosphate (arrows) in the col- 
lagen bundles of ENDSC, only observed in the 6-weeks implant. 
Furthermore fibroblasts (F) and a basophil-like cell (B) are present. 
Magnification 7142x. 
collagens (DSCs) with respect to their specific proper- 
ties, during subcutaneous implantation in rats. 
4.1. Relation between calcification 
and cytotoxicity 
Cytotoxic products can influence subjection to calci- 
fication of crosslinked collagen. 
Figure 8 Huge calcified collagen bundles of GDSC* 10 weeks after 
implantation. Magnification (a) 7142x and (b) 10752x. 
Results of Table I show that HDSC (with 50% 
cytotoxicity) induced calcification, while the same ma- 
terial, after removal of its cytotoxic products (see, 
HDSCtc and HDSC”, Table II) does not. Release of 
cytotoxic products will influence the tissue environ- 
ment and thereby, as observed, change subjection to 
calcification of the material. 
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With GDSCs also although giving a result opposite 
to HDSC, a relation between calcification and 
cytotoxicity was found. The severely cytotoxic GDSC 
85%) did not calcify, while the pretreated, very low 
cytotoxic GDSCtc already induced slight calcification 
5 days after implantation and the low cytotoxic 
GDSC? provoked severe calcification from 10 days on 
(Table III). 
As previously discussed [21, 311, high levels of re- 
sidual glutaraldehyde must be responsible for the se- 
vere cytotoxicity of GDSC. These residuals are not 
present in the case of GDSCtc and GDSC” and will 
therefore after implantation, result in a different tissue 
environment in comparison to GDSC, resulting in 
absence of calcification. However, with respect to the 
biocompatibility of GDSC it is not acceptable to rec- 
ommend this material as a non-calcifying material. 
These results show that the presence (moderate to 
severe levels) or absence of cytotoxic products can 
both define incidence of calcification of a crosslinked 
material. 
4.2. Relation between calcification 
and cellular infiltration 
After implantation of DSCs, no relation was found 
between calcification and cellular infiltration. 
First, with NDSC and NDSCtc cellular infiltration 
hardly occurred and calcification was not induced. 
However GDSCs with low cellular infiltration (see 
GDSCtc and GDSC”, Table I) did calcify, but in 
contrast to these, other crosslinked materials with low 
cellular infiltration (see HDSCtc and HDSC” Table I) 
did not. These results imply that there is no relation 
between (very) low cellular infiltration and calcifica- 
tion. 
With respect to moderate or high cellular infiltra- 
tion, which was observed with HDSC and GDSC, 
respectively, only HDSC was subjected to calcification 
(Tables II and III). 
Also after use of other crosslinking methods (activa- 
tion of carboxylic groups), i.e. ENDSC, and AaDSC, 
no relation between calcification and cellular infiltra- 
tion could be made. ENDSC, showed ‘delayed’ infilt- 
ration of cells, and although the material was com- 
pletely infiltrated after 3 weeks, calcification was only 
observed after 6 weeks of implantation. With AaDSC 
an inflammatory reaction, i.e. influx of monocytes 
[26], was observed from day 5 on, but only slight 
calcification was observed after 3 weeks of implanta- 
tion. 
With respect to the cellular infiltration, Schoen et al. 
[13] hypothesized that the potentiation of cellular 
damage at or near the material might have a promo- 
ting role in calcification. This hypothesis is in contrast 
with results of Grabenwoger et al. [14] and our find- 
ings with GDSC [24]. With the latter a lot of cell 
damage/debris was observed (Fig. 4), but no calcifica- 
tion was found up to 15 weeks after implantation. 
However, it might well be that the pathophysiologic 
environment (i.e. leaching of high levels of GA [21, 
311) overrules possible calcification as a consequence 
of cell damage/debris. 
4.3. Possible cause of calcification 
of the differently crosslinked DSCs 
NDSCs did not calcify and as discussed above calci- 
fication is not related to cellular infiltration. As a con- 
sequence, calcification of non-cytotoxic crosslinked 
DSCs must be due to the crosslinks induced. 
Modified GA crosslinking, i.e. highly crosslinked 
GDSC”, was found to induce severe amounts of calci- 
fication (Table III). With GDSC”, in contrast to com- 
mercially available GDSC, NaBH4 was used to reduce 
any unstable compounds present after crosslinking 
[32]. As a result cyclic bonds may be present among 
these stable crosslinks (e.g. pyridinium bonds) [31], 
and these might well function as a nucleation point for 
calcification. Previously, Levy et al. [39] also dis- 
cussed the presence of pyridinium crosslinks in GA- 
crosslinked collagen in relation to calcification, be- 
cause compounds similar to pyridinium were found in 
bone-derived collagen. Furthermore, Nimni et al. [40] 
suggested that a (di)pyridine structure, accounting for 
the high stability of the crosslinks, may be involved in 
calcification of GA-crosslinked collagens. This hy- 
pothesis is confirmed in the present study from the 
results with GDSC* (see explanation above), GDSCtc, 
and HDSC*. In GDSCtc, because no reduction agent 
was used, many unstable crosslinks and probably less 
stable cyclic crosslinks will be present [21,24,32]. The 
latter might be an explanation for very slight calcifica- 
tion of GDSCtc, mainly observed at the edges of the 
collagen bundles, in comparison with GDSC”. 
In contrast, optimal crosslinking of DSC with 
HMDIC (HDSC”) will neither result in unstable nor 
in cyclic crosslinks [21]. HDSC” did not calcify at all, 
which forms further evidence for possible involvement 
of cyclic crosslinks in the process of calcification. 
Furthermore, prevention of calcification was sug- 
gested by performing alternative crosslinkings, e.g. by 
activation of the carboxylic acid groups [16-181. Be- 
rnacca et al. [16] and others [17, IS] suggested that 
carboxyl residues should be involved and blockage of 
these groups, e.g. by crosslinking with acyl azide ac- 
tivation or by epoxy compounds pretreatment, should 
be effective in reducing calcification. Also from our 
study it is obvious, that alternative crosslinking 
methods (see ENDSC and AaDSC), in comparison to 
crosslinking with GA, clearly reduced calcification of 
the collagen. However, in our opinion this is not due 
to blockage of the carboxylic residues, because cross- 
linking with HMDIC, which only links via amino 
groups, did not induce calcification of the collagen. 
Furthermore, all DSCs of this group were sterilized by 
ethylene oxide which will block the remaining NH2 
groups of each type of DSC. This also proves that 
neither NH2, nor COOH- groups are involved in 
calcification. 
In summary we can conclude, that there is a strong 
relation between calcification and degree of cytoxicity. 
Furthermore, it is obvious that calcification is not 
related to cellular ingrowth but to the finally obtained 
crosslinked material, and possibly due to the presence 
of stable (cyclic) crosslinks in the collagen. 
From this fundamental study, it is clear that 
HDSC”, ENDSC and AaDSC are promising products 
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for several application sites. As discussed by Schoen et 
al. [14], the subcutaneous model proved to be a good 
model for studying calcification, despite the absence of 
dynamic mechanical stress which also may promote 
calcification [6, 411. Crosslinking of bioprosthetic 
heart valves by, for example, HMDIC can be very 
promising for the future. Finally, GDSC”, which in- 
duced severe calcification, could be a promising in- 
ducer of bone formation. 
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